358 related articles for article (PubMed ID: 27447975)
21. Identification of Hub Gene GRIN1 Correlated with Histological Grade and Prognosis of Glioma by Weighted Gene Coexpression Network Analysis.
Yang A; Wang X; Hu Y; Shang C; Hong Y
Biomed Res Int; 2021; 2021():4542995. PubMed ID: 34840971
[TBL] [Abstract][Full Text] [Related]
22. Chronic D609 treatment interferes with cell cycle and targets the expression of Olig2 in Glioma Stem like Cells.
Kalluri HSG; Kuo JS; Dempsey RJ
Eur J Pharmacol; 2017 Nov; 814():81-86. PubMed ID: 28802717
[TBL] [Abstract][Full Text] [Related]
23. A Glial Signature and Wnt7 Signaling Regulate Glioma-Vascular Interactions and Tumor Microenvironment.
Griveau A; Seano G; Shelton SJ; Kupp R; Jahangiri A; Obernier K; Krishnan S; Lindberg OR; Yuen TJ; Tien AC; Sabo JK; Wang N; Chen I; Kloepper J; Larrouquere L; Ghosh M; Tirosh I; Huillard E; Alvarez-Buylla A; Oldham MC; Persson AI; Weiss WA; Batchelor TT; Stemmer-Rachamimov A; Suvà ML; Phillips JJ; Aghi MK; Mehta S; Jain RK; Rowitch DH
Cancer Cell; 2018 May; 33(5):874-889.e7. PubMed ID: 29681511
[TBL] [Abstract][Full Text] [Related]
24. Regulatory networks driving expression of genes critical for glioblastoma are controlled by the transcription factor c-Jun and the pre-existing epigenetic modifications.
Roura AJ; Szadkowska P; Poleszak K; Dabrowski MJ; Ellert-Miklaszewska A; Wojnicki K; Ciechomska IA; Stepniak K; Kaminska B; Wojtas B
Clin Epigenetics; 2023 Feb; 15(1):29. PubMed ID: 36850002
[TBL] [Abstract][Full Text] [Related]
25. Post-translational Modifications of OLIG2 Regulate Glioma Invasion through the TGF-β Pathway.
Singh SK; Fiorelli R; Kupp R; Rajan S; Szeto E; Lo Cascio C; Maire CL; Sun Y; Alberta JA; Eschbacher JM; Ligon KL; Berens ME; Sanai N; Mehta S
Cell Rep; 2016 Jul; 16(4):950-966. PubMed ID: 27396340
[TBL] [Abstract][Full Text] [Related]
26. Coexpression network analysis identifies transcriptional modules related to proastrocytic differentiation and sprouty signaling in glioma.
Ivliev AE; 't Hoen PA; Sergeeva MG
Cancer Res; 2010 Dec; 70(24):10060-70. PubMed ID: 21159630
[TBL] [Abstract][Full Text] [Related]
27. 1p19q LOH patterns and expression of p53 and Olig2 in gliomas: relation with histological types and prognosis.
Durand KS; Guillaudeau A; Weinbreck N; DeArmas R; Robert S; Chaunavel A; Pommepuy I; Bourthoumieu S; Caire F; Sturtz FG; Labrousse FJ
Mod Pathol; 2010 Apr; 23(4):619-28. PubMed ID: 20081802
[TBL] [Abstract][Full Text] [Related]
28. Changes in chromatin state reveal ARNT2 at a node of a tumorigenic transcription factor signature driving glioblastoma cell aggressiveness.
Bogeas A; Morvan-Dubois G; El-Habr EA; Lejeune FX; Defrance M; Narayanan A; Kuranda K; Burel-Vandenbos F; Sayd S; Delaunay V; Dubois LG; Parrinello H; Rialle S; Fabrega S; Idbaih A; Haiech J; Bièche I; Virolle T; Goodhardt M; Chneiweiss H; Junier MP
Acta Neuropathol; 2018 Feb; 135(2):267-283. PubMed ID: 29149419
[TBL] [Abstract][Full Text] [Related]
29. The NF-κB RelB protein is an oncogenic driver of mesenchymal glioma.
Lee DW; Ramakrishnan D; Valenta J; Parney IF; Bayless KJ; Sitcheran R
PLoS One; 2013; 8(2):e57489. PubMed ID: 23451236
[TBL] [Abstract][Full Text] [Related]
30. Id2 mediates oligodendrocyte precursor cell maturation arrest and is tumorigenic in a PDGF-rich microenvironment.
Havrda MC; Paolella BR; Ran C; Jering KS; Wray CM; Sullivan JM; Nailor A; Hitoshi Y; Israel MA
Cancer Res; 2014 Mar; 74(6):1822-32. PubMed ID: 24425046
[TBL] [Abstract][Full Text] [Related]
31. Olig2 labeling index is correlated with histological and molecular classifications in low-grade diffuse gliomas.
Suzuki A; Nobusawa S; Natsume A; Suzuki H; Kim YH; Yokoo H; Nagaishi M; Ikota H; Nakazawa T; Wakabayashi T; Ohgaki H; Nakazato Y
J Neurooncol; 2014 Nov; 120(2):283-91. PubMed ID: 25085214
[TBL] [Abstract][Full Text] [Related]
32. Can oligodendrocyte transcriptional factor-2 (Olig2) be used as an alternative for 1p/19q co-deletions to distinguish oligodendrogliomas from other glial neoplasms?
Kurdi M; Alkhatabi H; Butt N; Albayjani H; Aljhdali H; Mohamed F; Alsinani T; Baeesa S; Almuhaini E; Al-Ghafari A; Hakamy S; Faizo E; Bahakeem B
Folia Neuropathol; 2021; 59(4):350-358. PubMed ID: 35114775
[TBL] [Abstract][Full Text] [Related]
33. The Oligodendrocyte Transcription Factor 2 OLIG2 regulates transcriptional repression during myelinogenesis in rodents.
Zhang K; Chen S; Yang Q; Guo S; Chen Q; Liu Z; Li L; Jiang M; Li H; Hu J; Pan X; Deng W; Xiao N; Wang B; Wang ZX; Zhang L; Mo W
Nat Commun; 2022 Mar; 13(1):1423. PubMed ID: 35301318
[TBL] [Abstract][Full Text] [Related]
34. SWIM tool application to expression data of glioblastoma stem-like cell lines, corresponding primary tumors and conventional glioma cell lines.
Fiscon G; Conte F; Paci P
BMC Bioinformatics; 2018 Nov; 19(Suppl 15):436. PubMed ID: 30497369
[TBL] [Abstract][Full Text] [Related]
35. Olig2 regulates terminal differentiation and maturation of peripheral olfactory sensory neurons.
Wang YZ; Fan H; Ji Y; Reynolds K; Gu R; Gan Q; Yamagami T; Zhao T; Hamad S; Bizen N; Takebayashi H; Chen Y; Wu S; Pleasure D; Lam K; Zhou CJ
Cell Mol Life Sci; 2020 Sep; 77(18):3597-3609. PubMed ID: 31758234
[TBL] [Abstract][Full Text] [Related]
36. Profiling Glioblastoma Cases with an Expression of DCX, OLIG2 and NES.
Odrzywolski A; Jarosz B; Kiełbus M; Telejko I; Ziemianek D; Knaga S; Rola R
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948016
[TBL] [Abstract][Full Text] [Related]
37. OLIG2 regulates lncRNAs and its own expression during oligodendrocyte lineage formation.
Wei H; Dong X; You Y; Hai B; Duran RC; Wu X; Kharas N; Wu JQ
BMC Biol; 2021 Jun; 19(1):132. PubMed ID: 34172044
[TBL] [Abstract][Full Text] [Related]
38. Oncogenes Activate an Autonomous Transcriptional Regulatory Circuit That Drives Glioblastoma.
Singh DK; Kollipara RK; Vemireddy V; Yang XL; Sun Y; Regmi N; Klingler S; Hatanpaa KJ; Raisanen J; Cho SK; Sirasanagandla S; Nannepaga S; Piccirillo S; Mashimo T; Wang S; Humphries CG; Mickey B; Maher EA; Zheng H; Kim RS; Kittler R; Bachoo RM
Cell Rep; 2017 Jan; 18(4):961-976. PubMed ID: 28122245
[TBL] [Abstract][Full Text] [Related]
39. Olig2 SUMOylation protects against genotoxic damage response by antagonizing p53 gene targeting.
Liu H; Weng W; Guo R; Zhou J; Xue J; Zhong S; Cheng J; Zhu MX; Pan SJ; Li Y
Cell Death Differ; 2020 Nov; 27(11):3146-3161. PubMed ID: 32483381
[TBL] [Abstract][Full Text] [Related]
40. Identification of
Lin H; Yang Y; Hou C; Zheng J; Lv G; Mao R; Xu P; Chen S; Zhou Y; Wang P; Zhou D
Genet Test Mol Biomarkers; 2021 May; 25(5):334-345. PubMed ID: 33970702
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
